| 000 | 01892 a2200493 4500 | ||
|---|---|---|---|
| 005 | 20250516001557.0 | ||
| 264 | 0 | _c20110106 | |
| 008 | 201101s 0 0 eng d | ||
| 022 | _a1096-9098 | ||
| 024 | 7 |
_a10.1002/jso.21661 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aLu, Xinchang | |
| 245 | 0 | 0 |
_aSorafenib induces growth inhibition and apoptosis of human chondrosarcoma cells by blocking the RAF/ERK/MEK pathway. _h[electronic resource] |
| 260 |
_bJournal of surgical oncology _cDec 2010 |
||
| 300 |
_a821-6 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't | ||
| 650 | 0 | 4 |
_aApoptosis _xdrug effects |
| 650 | 0 | 4 |
_aApoptosis Regulatory Proteins _xmetabolism |
| 650 | 0 | 4 |
_aBenzenesulfonates _xpharmacology |
| 650 | 0 | 4 | _aBlotting, Western |
| 650 | 0 | 4 |
_aBone Neoplasms _xdrug therapy |
| 650 | 0 | 4 | _aCell Line, Tumor |
| 650 | 0 | 4 |
_aCell Proliferation _xdrug effects |
| 650 | 0 | 4 |
_aChondrosarcoma _xdrug therapy |
| 650 | 0 | 4 |
_aCyclin D1 _xmetabolism |
| 650 | 0 | 4 |
_aExtracellular Signal-Regulated MAP Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 |
_aMitogen-Activated Protein Kinase Kinases _xantagonists & inhibitors |
| 650 | 0 | 4 |
_aNiacinamide _xanalogs & derivatives |
| 650 | 0 | 4 | _aPhenylurea Compounds |
| 650 | 0 | 4 |
_aPhosphorylation _xdrug effects |
| 650 | 0 | 4 |
_aProtein Kinase Inhibitors _xpharmacology |
| 650 | 0 | 4 |
_aProto-Oncogene Proteins c-bcl-2 _xmetabolism |
| 650 | 0 | 4 |
_aPyridines _xpharmacology |
| 650 | 0 | 4 |
_aSignal Transduction _xdrug effects |
| 650 | 0 | 4 | _aSorafenib |
| 650 | 0 | 4 |
_araf Kinases _xantagonists & inhibitors |
| 700 | 1 | _aTang, Xiaodong | |
| 700 | 1 | _aGuo, Wei | |
| 700 | 1 | _aRen, Tingting | |
| 700 | 1 | _aZhao, Hui | |
| 773 | 0 |
_tJournal of surgical oncology _gvol. 102 _gno. 7 _gp. 821-6 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/jso.21661 _zAvailable from publisher's website |
| 999 |
_c20145413 _d20145413 |
||